Added to YB: 2025-02-04
Pitch date: 2025-02-03
ALCAR.PA [neutral]
Carmat SA
-87.7%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally.
Market Cap
EUR 36.6M
Pitch Price
EUR 0.81
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.67
P/E
-0.54
EV/Sales
12.08
Sector
Health Care Equipment and Supplies
Category
N/A
Creams, Semis and Oil - Carmat
ALCAR.PA (overview): €9.7M raised at 29% discount, sustains ops till May 2025. Need €35M more for next year. 2024 sales €7M, aim to double in 2025. Medtech capital-intensive. Key: secure funding for growth vs dilution risk. Can they meet ambitious sales targets?
Read full article (1 min)